Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus

Naomi Balaban, Tzipora Goldkorn, Rachael T. Nhan, Luong B. Dang, Steven Scott, Rose M. Ridgley, Avraham Rasooly, Susan C. Wright, James W. Larrick, Reuven Rasooly, James R. Carlson

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.

Original languageEnglish (US)
Pages (from-to)438-440
Number of pages3
JournalScience
Volume280
Issue number5362
DOIs
StatePublished - Apr 17 1998

Fingerprint

Active Immunotherapy
Virulence
Staphylococcus aureus
Pathology
Bacterial Toxins
Proteins
RNA
Bacteria
Skin
Peptides
Staphylococcus aureus RNAIII
Infection
RNAIII inhibiting peptide
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Balaban, N., Goldkorn, T., Nhan, R. T., Dang, L. B., Scott, S., Ridgley, R. M., ... Carlson, J. R. (1998). Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science, 280(5362), 438-440. https://doi.org/10.1126/science.280.5362.438

Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. / Balaban, Naomi; Goldkorn, Tzipora; Nhan, Rachael T.; Dang, Luong B.; Scott, Steven; Ridgley, Rose M.; Rasooly, Avraham; Wright, Susan C.; Larrick, James W.; Rasooly, Reuven; Carlson, James R.

In: Science, Vol. 280, No. 5362, 17.04.1998, p. 438-440.

Research output: Contribution to journalArticle

Balaban, N, Goldkorn, T, Nhan, RT, Dang, LB, Scott, S, Ridgley, RM, Rasooly, A, Wright, SC, Larrick, JW, Rasooly, R & Carlson, JR 1998, 'Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus', Science, vol. 280, no. 5362, pp. 438-440. https://doi.org/10.1126/science.280.5362.438
Balaban, Naomi ; Goldkorn, Tzipora ; Nhan, Rachael T. ; Dang, Luong B. ; Scott, Steven ; Ridgley, Rose M. ; Rasooly, Avraham ; Wright, Susan C. ; Larrick, James W. ; Rasooly, Reuven ; Carlson, James R. / Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. In: Science. 1998 ; Vol. 280, No. 5362. pp. 438-440.
@article{3d5d5b944ca64130913534710b29d027,
title = "Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus",
abstract = "Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.",
author = "Naomi Balaban and Tzipora Goldkorn and Nhan, {Rachael T.} and Dang, {Luong B.} and Steven Scott and Ridgley, {Rose M.} and Avraham Rasooly and Wright, {Susan C.} and Larrick, {James W.} and Reuven Rasooly and Carlson, {James R.}",
year = "1998",
month = "4",
day = "17",
doi = "10.1126/science.280.5362.438",
language = "English (US)",
volume = "280",
pages = "438--440",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5362",

}

TY - JOUR

T1 - Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus

AU - Balaban, Naomi

AU - Goldkorn, Tzipora

AU - Nhan, Rachael T.

AU - Dang, Luong B.

AU - Scott, Steven

AU - Ridgley, Rose M.

AU - Rasooly, Avraham

AU - Wright, Susan C.

AU - Larrick, James W.

AU - Rasooly, Reuven

AU - Carlson, James R.

PY - 1998/4/17

Y1 - 1998/4/17

N2 - Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.

AB - Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.

UR - http://www.scopus.com/inward/record.url?scp=0032540422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032540422&partnerID=8YFLogxK

U2 - 10.1126/science.280.5362.438

DO - 10.1126/science.280.5362.438

M3 - Article

C2 - 9545222

AN - SCOPUS:0032540422

VL - 280

SP - 438

EP - 440

JO - Science

JF - Science

SN - 0036-8075

IS - 5362

ER -